<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05104749</url>
  </required_header>
  <id_info>
    <org_study_id>0012021</org_study_id>
    <nct_id>NCT05104749</nct_id>
  </id_info>
  <brief_title>Homeopathic Treatment of Post-acute COVID-19 Syndrome</brief_title>
  <official_title>Homeopathic Treatment of Post-acute COVID-19 Syndrome- A Pilot Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest College of Naturopathic Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Samueli Institute for Information Biology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Southwest College of Naturopathic Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether an individually prescribed homeopathic medicine has an effect greater&#xD;
      than a placebo and is a viable treatment option to improve fatigue and quality of life for&#xD;
      patients suffering from the symptoms of Post-acute COVID-19 Syndrome. The researchers hope to&#xD;
      achieve this goal by conducting a clinical trial that is scientifically rigorous and&#xD;
      clinically relevant. Expected results of this pilot study will be to obtain sufficient&#xD;
      experience and preliminary feasibility data to justify a larger clinical trial of this&#xD;
      hypothesis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The researchers objectives for the study are to: 1) identify efficient means of recruiting&#xD;
      subjects, 2) test and refine the initial study design and treatment protocol, 3) evaluate the&#xD;
      instruments for assessing treatment outcomes, 4) estimate sample sizes that will be required&#xD;
      in the full-scale trial, 5) determine which homeopathic medicines are most often prescribed&#xD;
      for this syndrome, and 6) determine whether there is a measurable effect size difference or&#xD;
      positive trend in reduction of symptoms in patients treated with homeopathy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, double-blind, placebo-controlled clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Both study medication and placebo are identical in appearance, odor, and taste. Statistician will be blinded as to treatment group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Fatigue Assessment Scale (FAS)</measure>
    <time_frame>Baseline</time_frame>
    <description>General fatigue questionnaire to assess fatigue. A total FAS score &lt; 22 indicates no fatigue, a score ≥ 22 indicates fatigue.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Fatigue Assessment Scale (FAS)</measure>
    <time_frame>4, 8, and 12 weeks</time_frame>
    <description>General fatigue questionnaire to assess fatigue. A total FAS score &lt; 22 indicates no fatigue, a score ≥ 22 indicates fatigue.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>36 Item Short Form Survey (SF 36)</measure>
    <time_frame>Baseline</time_frame>
    <description>Quality of life measure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in 36 Item Short Form Survey (SF 36)</measure>
    <time_frame>4, 8, and 12 weeks</time_frame>
    <description>Quality of life measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure Yourself Medical Outcomes Profile (MYMOP)</measure>
    <time_frame>Baseline</time_frame>
    <description>Patient specific outcome tool to assess general health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure Yourself Medical Outcomes Profile (MYMOP)</measure>
    <time_frame>12 weeks or at withdrawl</time_frame>
    <description>Patient specific outcome tool to assess general health</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Post-acute Covid-19 Syndrome</condition>
  <arm_group>
    <arm_group_label>Homeopathic Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individualized homeopathic medicines on impregnated lactose pellets will be prescribed to each participant based on the totality of their physical, emotional, and mental symptoms. All medicines prescribed are listed in the Homeopathic Pharmacopoeia of the United States (HPUS) as outlined in the Food, Drug, and Cosmetics Act of 1939</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Identical lactose pellets in size, odor, and taste without the impregnated homeopathic medicines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Homeopathic Medication</intervention_name>
    <description>Homeopathic medicines are prepared according to standardized methods as specified by the Homeopathic Pharmacopoeia of the United States (HPUS), which was mandated by Congress to regulate the manufacture of homeopathic medicines as part of the Food, Drug, and Cosmetics Act of 1939. All homeopathic medicines prescribed in this study must be found in the HPUS. For a complete list of homeopathic medicines, contact the researchers.</description>
    <arm_group_label>Homeopathic Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Inert lactose pellets</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages 18-64&#xD;
&#xD;
          -  Any ethnicity&#xD;
&#xD;
          -  Adequate cognitive function to be able to give informed consent&#xD;
&#xD;
          -  Technologically competent to complete web forms and perform video calls&#xD;
&#xD;
          -  Positive PCR test (polymerase chain reaction) result for SARS-CoV-2 (severe acute&#xD;
             respiratory syndrome coronavirus 2)&#xD;
&#xD;
          -  Persistent fatigue for a minimum of 60 days since diagnosis of Covid-19.&#xD;
&#xD;
          -  A fatigue score above 21 in the Fatigue Assessment Scale upon enrollment&#xD;
&#xD;
          -  Full Covid-19 vaccination; i.e. 2 weeks after a two-dose series (Pfizer or Moderna) or&#xD;
             2 weeks after a single-dose vaccine (Johnson &amp; Johnson)&#xD;
&#xD;
          -  Willing to fill out regular questionnaires&#xD;
&#xD;
          -  Willing to use homeopathic medicines&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinically significant kidney, heart, or hepatic impairment as determined by clinical&#xD;
             judgment&#xD;
&#xD;
               -  Previous hospitalization in ICU for Covid-19&#xD;
&#xD;
               -  Partial Covid vaccination or unvaccinated for Covid-19&#xD;
&#xD;
               -  Diagnosis of Chronic Fatigue Syndrome, Fibromyalgia, or Lyme disease prior to&#xD;
                  Covid-19&#xD;
&#xD;
               -  Chronic psychiatric illness or neurological illness prior to Covid-19 diagnosis&#xD;
                  Taking opioid analgesics, opioid dependence or undergoing treatment for substance&#xD;
                  abuse or addiction&#xD;
&#xD;
               -  Taking steroid medication or immunosuppressive medications&#xD;
&#xD;
               -  Suspected or confirmed pregnancy or breastfeeding&#xD;
&#xD;
               -  Active cancers&#xD;
&#xD;
               -  Current treatment by a homeopathic practitioner&#xD;
&#xD;
               -  Initiation of another treatment for Long Covid within the past 2 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth Rice, ND</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southwest College of Naturopathic Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth Rice, ND</last_name>
    <phone>480-276-3808</phone>
    <email>e.rice@scnm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Jacobs, MD, MPH</last_name>
    <phone>206-669-2522</phone>
    <email>jjacobs@igc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southwest College of Naturopathic Medicine</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85282</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Rice, ND</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 28, 2021</study_first_submitted>
  <study_first_submitted_qc>November 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southwest College of Naturopathic Medicine</investigator_affiliation>
    <investigator_full_name>Elizabeth Rice</investigator_full_name>
    <investigator_title>Associate Professor Interim Dept Chair Homeopathy and Pharmacology</investigator_title>
  </responsible_party>
  <keyword>Long Covid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

